Supernus Pharmaceuticals (SUPN)

6.30 +0.04  +0.64%  May 21, 8:00PM
Add to Watchlists Create an Alert

Supernus Pharmaceuticals Cash and Equivalents

View Full Chart

Supernus Pharmaceuticals Cash and Equivalents Chart

View Cash and Equivalents for SUPN.
Start Your YCharts Pro Platinum Membership.

Supernus Pharmaceuticals Historical Cash and Equivalents Data

Pro Data Export
Dates:  to
Viewing 1 of 1   First  Previous First    Next  Last   Last

There is no data for the selected date range.

Data for this Date Range  
Dec. 31, 2012 Go Pro
Sept. 30, 2012 Go Pro
June 30, 2012 Go Pro
March 31, 2012 Go Pro
Dec. 31, 2011 Go Pro
   
Sept. 30, 2011 Go Pro
Dec. 31, 2010 Go Pro
Sept. 30, 2010 Go Pro
Dec. 31, 2009 Go Pro

About Cash and Equivalents

Cash and equivalents is cash or cash equivalents that a company possesses at any given time. Examples of cash equivalents are: money market accounts, treasury bills, and short term government bonds. Cash and cash equivalents are a business' most liquid assets. Cash on hand results from a positive cash flow statement.

Investors look at cash on hand as a reflection of a company's solvency and liquidity.
Learn More

View Cash and Equivalents for SUPN.
Start Your YCharts Pro Platinum Membership.

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.

YCharts Pro is only $199/month, and comes with a 14-day free trial.

Get Started Now

Already a YCharts Pro Platinum Member? Sign in here.